Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Cancer Control : Journal of the Moffitt Cancer Center|September 16, 2024
Survival Dynamics in Advanced Ovarian Cancer: R2 Resection Versus No-Surgery Paths ExploredKonstantinos Pitsikakis, Diederick DeJong, Konstantinos Kitsos-Kalyvianakis, et al.Journal of Ovarian Research|November 11, 2023
Prerequisites to improve surgical cytoreduction in FIGO stage III/IV epithelial ovarian cancer and subsequent clinical ramificationsDiederick de Jong, Amudha Thangavelu, Timothy Broadhead, et al.Cancer Control : Journal of the Moffitt Cancer Center|October 25, 2021
Feature Selection is Critical for 2-Year Prognosis in Advanced Stage High Grade Serous Ovarian Cancer by Using Machine LearningAlexandros Laios, Angeliki Katsenou, Yong Sheng Tan, et al.Diagnostics (Basel, Switzerland)|January 11, 2024
Explaining the Elusive Nature of a Well-Defined Threshold for Blood Transfusion in Advanced Epithelial Ovarian Cancer Cytoreductive SurgeryAlexandros Laios, Evangelos Kalampokis, Marios-Evangelos Mamalis, et al.Molecular Cancer|April 30, 2008
Potential role of miR-9 and miR-223 in recurrent ovarian cancerAlexandros Laios, Sharon O'Toole, Richard Flavin, et al.Journal of Ovarian Research|January 21, 2012
Suppression of cancer stemness p21-regulating mRNA and microRNA signatures in recurrent ovarian cancer patient samplesMichael F Gallagher, Cynthia Cbb Heffron, Alexandros Laios, et al.Gynecologic Oncology|November 27, 2025
Prognostic and immunological significance of tryptophan metabolic enzymes across endometrial cancer molecular subtypesRacheal Louise Johnson, Georgia Mappa, Narinder Gahir, et al.Current Oncology (Toronto, Ont.)|December 22, 2022
Stratification of Length of Stay Prediction following Surgical Cytoreduction in Advanced High-Grade Serous Ovarian Cancer Patients Using Artificial Intelligence; the Leeds L-AI-OS ScoreAlexandros Laios, Daniel Lucas Dantas De Freitas, Gwendolyn Saalmink, et al.Journal of Clinical Medicine|January 11, 2022
Machine Learning-Based Risk Prediction of Critical Care Unit Admission for Advanced Stage High Grade Serous Ovarian Cancer Patients Undergoing Cytoreductive Surgery: The Leeds-Natal ScoreAlexandros Laios, Raissa Vanessa De Oliveira Silva, Daniel Lucas Dantas De Freitas, et al.International Journal of Molecular Sciences|January 24, 2013
Pre-Treatment of platinum resistant ovarian cancer cells with an MMP-9/MMP-2 inhibitor prior to cisplatin enhances cytotoxicity as determined by high content screeningAlexandros Laios, Bashir M Mohamed, Lynn Kelly, et al.Pageof 5